Manufacturer
INTAS PHARM LTD
Contents
Pantoprazole
Indication
Peptic ulcer, Gastro-oesophageal reflux disease, Prophylaxis of NSAID-induced ulcers, Zollinger-Ellison syndrome
Instruction
May be taken with or without food.
Drug interaction
May decrease plasma concentrations of rilpivirine and atazanavir. Increased risk of hypomagnesaemia with diuretics. Increased risk of digoxin-induced cardiotoxic effects. May increase INR and prothrombin time of warfarin. May increase plasma concentration of methotrexate. May decrease absorption of itraconazole, ketoconazole, posaconazole, erlotinib. May diminish the therapeutic effect of clopidogrel.
Malaysia
